Journals / Journal of Urological Surgery / 2019 / Cilt: 6 - Sayı: 4

Sekonder Prostat Tümörleri

Secondary Tumors of the Prostate

Pages
339–342
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Bu derlemede, prostatın nadir görülen sekonder tümörlerinin tanı ve tedavi açısından önemi vurgulanmaktadır.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Prostatın sekonder tümörleri doğrudan invazyonla ya da lenfatik ya da kan dolaşımı yoluyla prostata ulaşan tümörlerdir.
📊
Key Findings & Data:İnvazyonla prostata ulaşan tümörler komşu organ tümörleridir.
💡
Conclusion & Impact:Bu derlemede, prostatın nadir görülen sekonder tümörlerinin tanı ve tedavi açısından önemi vurgulanmaktadır.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Prostatın sekonder tümörleri doğrudan invazyonla ya da lenfatik ya da kan dolaşımı yoluyla prostata ulaşan tümörlerdir. İnvazyonla prostata ulaşan tümörler komşu organ tümörleridir. Metastaz ile prostata ulaşan tümörler ise en sık akciğer kanserleridir. Özellikle ürotelyal tümörler primer ya da sekonder olabilirler. Primer ya da sekonder ürotelyal karsinomlar sıklıkla primer prostat adenokarsinomu ile birliktelik gösterir. Özellikle genç yaşlarda prostatta tümör varlığında metastazlar akla gelmelidir. Bu derlemede, prostatın nadir görülen sekonder tümörlerinin tanı ve tedavi açısından önemi vurgulanmaktadır.

Özet

In secondary tumors of the prostate, there is an invasion to the prostate directly via lymphatic route or blood circulation. Tumors invading the prostate are defined as adjacent organ tumors. The most common cancers that spread to the prostate are lung cancers. Especially urothelial tumors may be primary or secondary. Primary or secondary urothelial carcinomas are generally associated with primary prostate adenocarcinoma. Metastasis should be considered in young patients with a prostate tumor. The aim of this review was to emphasize the importance of prompt diagnosis and early treatment of secondary tumors involving the prostate which are uncommon.

🔖

Cite This Article

ERDEM, H. (2019). Sekonder Prostat Tümörleri. Journal of Urological Surgery, Cilt: 6 - Sayı: 4, 339–342. https://ajindex.com/articles/197695

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A.Global cancer statistics 2018: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin 2018;68:394-424
  2. Mahul B. Amin Satish K. Tickoo. Section 3: Prostate Gland & Seminal Vesicle. Diagnostic Pathology: Genitourinary. 2nd Edition. Elsevier. 2016.pp:708- 716
  3. Abdelhalim A, El-Hawary AK, Helmy TE, Dawaba ME, El-Baz MA, Elashry R, Hafez AT. Primary Yolk Sac Tumor of the Prostate in a Child: Case Report. Clin Genitourin Cancer 2016;14:e535-e537
  4. Janowitz T, Welsh S, Warren AY, Robson J, Thomas B, Shaw A, Ainsworth NL, Neal DE, Mazhar D. Prostatic relapse of an undifferentiated teratoma 24 years after orchidectomy. BMC Res Notes 2015;8:524
  5. Tosev G, Kuru TH, Huber J, Freier G, Bergmann F, Hassel JC, Pahernik SA, Hohenfellner M, Hadaschik BA. Primary melanoma of the prostate: case report and review of the literature. BMC Urology 2015;15:68
  6. Dailey VL, Hameed O. Blue nevus of the prostate. Arch Pathol Lab Med 2011;135:799–802
  7. Ayyathurai R, Gomez P, Luongo T, Soloway MS, Manoharan M. Prostatic involvement by urothelial carcinoma of the bladder: clinicopathological features and outcome after radical cystectomy. BJU Int 2007;100:1021- 1025
  8. Autorino R, Di Lorenzo G, Damiano R, Giannarini G, De Sio M, Cheng L, Montironi R. Pathology of the prostate in radical cystectomy specimens: a critical review. Surg Oncol 2009;18:73-84
  9. Singh A, Jones RF, Friedman H, Hathir S, Soos G, Zabo A, Haas GP. Expression of p53 and pRb in bladder and prostate cancers of patients having both cancers. Anticancer Res 1999;19:5415-5417
  10. Ayala G, Frolov A, Chatterjee D, He D, Hilsenbeck S, Ittmann M. Expression of ERG protein in prostate cancer: variability and biological correlates. Endocr Relat Cancer 2015;22:277-287
  11. Gurel B, Ali TZ, Montgomery EA, Begum S, Hicks J, Goggins M, Eberhart CG, Clark DP, Bieberich CJ, Epstein JI, De Marzo AM. NKX3.1 as a marker of prostatic origin in metastatic tumors. Am J Surg Pathol 2010;34:1097-1105
  12. Amara N, Palapattu GS, Schrage M, Gu Z, Thomas GV, Dorey F, Said J, Reiter RE. Prostate stem cell antigen is overexpressed on human transitional cell carcinoma.Cancer Res. 2001;61:4660-4665
  13. Genega EM, Hutchinson B, Reuter VE, Gaudin PB. Immunophenotypeof high-grade prostatic adenocarcinoma and urothelial carcinoma. Mod Pathol 2000;13:1186-1191
  14. Androulakakis PA, Schneider HM, Jacobi GH, Hohenfellner R.